SEL1L3 and hepatocellular carcinoma: SEL1L3 was identified as one of ten common mitochondrial defect (CMD) genes, and was shown to contribute to CMD-mediated regulatory mechanism, resulting in mitochondrial defect and subsequent retrograde signals for transcriptional reprogramming during hepatocellular carcinoma progression [75].